T Cell Immunotherapy for Advanced Ovarian Cancer
Condition: Platinum Resistant Ovarian Cancer Interventions: Procedure: Leukapheresis; Drug: Utomilumab; Drug: Cyclophosphamide; Biological: T Cell Infusion; Drug: Interleukin-2 Sponsors: M.D. Anderson Cancer Center; Immatics US, Inc.; Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Immunotherapy | Ovarian Cancer | Ovaries | Pfizer | Research